Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Patient Square Capital LP
Form 13F · Q2 2026

Patient Square Capital LP

CIK 1819257Filed 2026-08-1213F-HR View the filing on EDGAR ↗
$646M
Reported book value
23
Positions
12
Quarters on record
Top 50
Positions

Patient Square Capital LP — holdings

Top 23 positions of 23, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1ROIV Roivant Sciences Ltd8.0M−1.8%$284M44.0%
2RVMD Revolution Medicines Inc276,000—$52M8.0%
3MIRM Mirum Pharmaceuticals Inc260,500+13.3%$30M4.7%
4ABVX Abivax Sa206,500+70.3%$28M4.3%
5ONC Beone Medicines Ltd90,020+11.8%$26M4.0%
6PHVS Pharvaris N V671,209+36.1%$23M3.6%
7ARGX Argenx Se23,000−37.4%$21M3.3%
8UTHR United Therapeutics Corp Del37,120—$20M3.1%
9BLTE Belite Bio Inc110,000−5.7%$17M2.6%
10COGT Cogent Biosciences Inc425,000−28.7%$16M2.5%
11DBVT Dbv Technologies S A909,474+31.1%$15M2.3%
12XENE Xenon Pharmaceuticals Inc220,000−3.1%$13M2.1%
13BNTX Biontech Se134,429—$13M1.9%
14RCUS Arcus Biosciences Inc355,800+82.5%$11M1.7%
15ELVN Enliven Therapeutics Inc212,500+6.2%$11M1.7%
16DNTH Dianthus Therapeutics Inc108,000+15.0%$11M1.6%
17ALLO Allogene Therapeutics Inc5.0M+46.4%$11M1.6%
18EYPT Eyepoint Inc720,000−9.4%$10M1.6%
19ARQT Arcutis Biotherapeutics Inc370,000−7.6%$10M1.5%
20CCCC C4 Therapeutics Inc1.6M—$8M1.2%
21IVA Inventiva Sa2.0M—$7M1.2%
22KYMR Kymera Therapeutics Inc47,500−52.5%$5M0.8%
23FTH Faeth Therapeutics Inc175,050—$4M0.7%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.